UNIFORM PRESCRIPTION BLANKS LAW AND PUBLIC SAFETY
Chapter 45A, Subchapter 27 Page 5 of 17 Last Revision Date: 3/17/2014
b) A licensed prescriber affiliated with a healthcare facility licensed pursuant to P.L. 1971, c. 136
(N.J.S.A. 26:2H-1 et seq.), may use the NJPB of the licensed facility provided that:
1) The prescription is written for a patient treated at that healthcare facility;
2) The name and license number of the licensed prescriber, and the prescriber’s National Provider
Identifier (NPI) number, if the prescriber has obtained an NPI number, is legibly written, typed,
stamped or otherwise affixed to the NJPB;
3) The prescription contains the signature of the licensed prescriber; and
4) If the prescription is for a controlled dangerous substance, the licensed prescriber’s Federal
Drug Enforcement Administration (DEA) registration number shall be pre-printed, legibly
written, typed, stamped, or otherwise affixed to the NJPB.
c) A separate NJPB shall be utilized for each prescription written for a controlled dangerous substance.
The licensed prescriber's Federal DEA registration number shall be pre-printed, legibly written,
typed, stamped, or otherwise affixed to the NJPB. No other medication shall appear on the
prescription.
d) If a licensed prescriber utilizes an NJPB pre-printed with multiple drugs, the prescriber shall
obliterate, by a cross-off procedure, any drug that is not being prescribed.
e) A prescription transmitted verbally or transmitted electronically by telephone, facsimile, modem or
other means to a pharmacy by a licensed prescriber shall be exempt from the requirement of
utilizing an NJPB if the licensed prescriber provides the pharmacist with his or her license number,
DEA number, as appropriate to the particular prescription and NPI number, if the prescriber has
obtained an NPI number, at the time of transmission of the prescription, and the pharmacist
satisfies the requirements of N.J.A.C. 13:39-7.10, 7.11, or 9.27.
1) A prescriber licensed by the State Board of Medical Examiners who transmits a facsimile or
electronic prescription shall also comply with all requirements set forth in N.J.A.C. 13:35-7.4 and
7.4A.
f) A licensed prescriber writing a prescription for a Schedule II narcotic substance to be compounded
for direct administration to a patient by parenteral, intravenous, intramuscular, subcutaneous or
intraspinal infusion, or a prescription for a Schedule II narcotic substance for a hospice patient, or a
prescription for any Schedule II substance for a long-term care facility resident, shall be exempt from